Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
Center for Information Technology and Statistics, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
BMC Cardiovasc Disord. 2021 Mar 2;21(1):120. doi: 10.1186/s12872-021-01932-8.
Organ malperfusion is a lethal complication in acute type B aortic dissection (ATBAD). The aim of present study is to develop a nomogram integrated with metabolic acidosis to predict in-hospital mortality and organ malperfusion in patients with ATBAD undergoing thoracic endovascular aortic repair (TEVAR).
The nomogram was derived from a retrospectively study of 286 ATBAD patients who underwent TEVAR from 2010 to 2017 at a single medical center. Model performance was evaluated from discrimination and calibration capacities, as well as clinical effectiveness. The results were validated using a prospective study on 77 patients from 2018 to 2019 at the same center.
In the multivariate analysis of the derivation cohort, the independent predictors of in-hospital mortality and organ malperfusion identified were base excess, maximum aortic diameter ≥ 5.5 cm, renal dysfunction, D-dimer level ≥ 5.44 μg/mL and albumin amount ≤ 30 g/L. The penalized model was internally validated by bootstrapping and showed excellent discriminatory (bias-corrected c-statistic, 0.85) and calibration capacities (Hosmer-Lemeshow P value, 0.471; Brier Score, 0.072; Calibration intercept, - 0.02; Slope, 0.98). After being applied to the external validation cohort, the model yielded a c-statistic of 0.86 and Brier Score of 0.097. The model had high negative predictive values (0.93-0.94) and moderate positive predictive values (0.60-0.71) for in-hospital mortality and organ malperfusion in both cohorts.
A predictive nomogram combined with base excess has been established that can be used to identify high risk ATBAD patients of developing in-hospital mortality or organ malperfusion when undergoing TEVAR.
器官灌注不良是急性 B 型主动脉夹层(ATBAD)的致命并发症。本研究旨在开发一种整合代谢性酸中毒的列线图,以预测接受胸主动脉腔内修复术(TEVAR)的 ATBAD 患者的住院死亡率和器官灌注不良。
该列线图来自于 2010 年至 2017 年在一家医疗中心接受 TEVAR 的 286 例 ATBAD 患者的回顾性研究。通过区分和校准能力以及临床效果评估模型性能。使用同一中心 2018 年至 2019 年的 77 例前瞻性研究对结果进行验证。
在推导队列的多变量分析中,确定的住院死亡率和器官灌注不良的独立预测因子是碱剩余、最大主动脉直径≥5.5cm、肾功能障碍、D-二聚体水平≥5.44μg/mL 和白蛋白量≤30g/L。通过自举法对内嵌模型进行内部验证,显示出良好的区分(校正后 c 统计量,0.85)和校准能力(Hosmer-Lemeshow P 值,0.471;Brier 评分,0.072;校准截距,-0.02;斜率,0.98)。应用于外部验证队列后,该模型的 c 统计量为 0.86,Brier 评分为 0.097。该模型在两个队列中对住院死亡率和器官灌注不良均具有较高的阴性预测值(0.93-0.94)和中等阳性预测值(0.60-0.71)。
已经建立了一种预测列线图,该列线图结合碱剩余可用于识别接受 TEVAR 的 ATBAD 患者发生住院死亡率或器官灌注不良的高风险患者。